5-羟色胺3型受体拮抗剂BRL 43694与顺铂所致恶心和呕吐 - Suppr

Suppr

超能文献

The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.

作者信息

Carmichael J, Cantwell B M, Edwards C M, Rapeport W G, Harris A L

机构信息

University Department of Clinical Oncology, Newcastle General Hospital, Newcastle upon Tyne.

出版信息

BMJ. 1988 Jul 9;297(6641):110-1. doi: 10.1136/bmj.297.6641.110.

DOI:10.1136/bmj.297.6641.110

PMID:2841996

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1833825/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de79/1833825/c847de3f1c19/bmj00294-0035-a.jpg

相似文献

The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.5-羟色胺3型受体拮抗剂BRL 43694与顺铂所致恶心和呕吐

BMJ. 1988 Jul 9;297(6641):110-1. doi: 10.1136/bmj.297.6641.110.

The 5-HT3 antagonist, BRL 43694, does not compromise the efficacy of cisplatin in tumour-bearing mice.5-羟色胺3拮抗剂BRL 43694不会损害顺铂对荷瘤小鼠的疗效。

Cancer Chemother Pharmacol. 1990;25(5):377-9. doi: 10.1007/BF00686242.

[BRL 43694A--a 5-hydroxytryptamine receptor blocker as an antiemetic in cytostatic therapy].[BRL 43694A——一种5-羟色胺受体阻滞剂，作为细胞抑制疗法中的止吐药]

Schweiz Med Wochenschr. 1989 Jun 10;119(23):831-4.

Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting.格拉司琼的I/II期试验：一种用于预防化疗引起的恶心和呕吐的新型5-羟色胺拮抗剂

J Clin Oncol. 1990 Feb;8(2):337-41. doi: 10.1200/JCO.1990.8.2.337.

A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting.新型5HT3受体拮抗剂BRL43694A预防化疗引起的恶心和呕吐的I期研究。

Cancer Chemother Pharmacol. 1989;24(3):193-6. doi: 10.1007/BF00300242.

First clinical study of the selective 5-HT3 antagonist, granisetron (BRL 43694), in the acute treatment of migraine headache.选择性5-羟色胺3拮抗剂格拉司琼（BRL 43694）治疗偏头痛急性发作的首次临床研究。

Headache. 1991 May;31(5):296-7. doi: 10.1111/j.1526-4610.1991.hed3105296.x.

BRL 43694.BRL 43694.

Cancer Invest. 1989;7(5):535. doi: 10.3109/07357908909041391.

A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational study.

Neth J Med. 1992 Jun;40(5-6):221-6.

A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group.接受高剂量顺铂治疗的患者中两种剂量格拉司琼的比较。格拉司琼研究组。

Eur J Cancer. 1990;26 Suppl 1:S15-9.

Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: a summary.格拉司琼（BRL 43694）用于治疗细胞毒性药物引起的呕吐：综述

Cancer Treat Rev. 1990 Sep;17(2-3):307-10. doi: 10.1016/0305-7372(90)90062-k.

引用本文的文献

Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.成人止吐药预防中度或高度致吐性化疗引起的恶心和呕吐：网状荟萃分析。

Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD012775. doi: 10.1002/14651858.CD012775.pub2.

Pharmacological Agents Affecting Emesis : A Review (Part II).影响呕吐的药物制剂：综述（第二部分）

Drugs. 1992 Apr;43(4):443-463. doi: 10.2165/00003495-199243040-00003.

[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].[化疗引起的呕吐的管理：经过20年临床研究后何为标准]

Med Klin (Munich). 1998 Jan;93 Suppl 1:3-17. doi: 10.1007/BF03041988.

The effects of gamma-radiation on intestinal motor activity and faecal pellet expulsion in the guinea pig.

Dig Dis Sci. 1996 Dec;41(12):2307-16. doi: 10.1007/BF02100119.

The antiemetic activity of granisetron against cytostatic-treatment-induced emesis in 10- to 13-week-old ferrets.格拉司琼对10至13周龄雪貂细胞毒性治疗引起的呕吐的止吐活性。

J Cancer Res Clin Oncol. 1994;120(4):204-7. doi: 10.1007/BF01372557.

Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.用于预测5-羟色胺3受体拮抗剂止吐活性的志愿者模型。

Br J Clin Pharmacol. 1994 Jun;37(6):525-30. doi: 10.1111/j.1365-2125.1994.tb04298.x.

Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities.减轻化疗引起的恶心和呕吐。当前观点与未来可能性

Drug Saf. 1993 Dec;9(6):410-28. doi: 10.2165/00002018-199309060-00004.

Chemotherapy induced emesis--mechanisms and treatment: a review.化疗引起的呕吐——机制与治疗：综述

J R Soc Med. 1988 Nov;81(11):658-62. doi: 10.1177/014107688808101115.

Arginine vasopressin--a mediator of chemotherapy induced emesis?精氨酸加压素——化疗所致呕吐的介质？

Br J Cancer. 1989 Mar;59(3):467-70. doi: 10.1038/bjc.1989.96.

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.5-羟色胺3受体拮抗剂BRL 43694的止吐潜力

Br J Cancer. 1988 Nov;58(5):644-50. doi: 10.1038/bjc.1988.277.

本文引用的文献

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.大剂量顺铂给药后迟发性恶心和呕吐的发生率、病程及严重程度。

J Clin Oncol. 1985 Oct;3(10):1379-84. doi: 10.1200/JCO.1985.3.10.1379.

Extrapyramidal reactions with metoclopramide.胃复安引起的锥体外系反应。

Br Med J (Clin Res Ed). 1985 Oct 5;291(6500):930-2. doi: 10.1136/bmj.291.6500.930.

Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist.

Lancet. 1987 Jun 27;1(8548):1461-3. doi: 10.1016/s0140-6736(87)92208-2.

Blockade of neuronal tryptamine receptors by metoclopramide.甲氧氯普胺对神经元色胺受体的阻断作用。

Eur J Pharmacol. 1978 May 1;49(1):109-12. doi: 10.1016/0014-2999(78)90228-5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验